Sanquin Home Sanquin Home Sanquin
Home ● Contact ● Sanquin ● News ● Jobs ● Sitemap ●
Diagnostic Services
 		●
Products
 		●
Research
 		●
Education & Training
 		●
Business Activities
Co-development
Sanquin research and development departments at various divisions aim to cooperate with companies active in research fields compatible with the research performed in its departments and with companies that are active as suppliers in the areas were Sanquin is active. Sanquin Research in line with Sanquin's mission, is active in Hematology, Immunology, Virology, Plasma Proteins and Inflammation. The Research & Development departments at the four Sanquin Blood Bank divisons are active in clinical research, transfusion technology, clinical evaluation of transfusion technology, and donor studies. Also Sanquin Diagnostic Services is often involved in co-development. Through co-development activities we aim to create added value to the technology/product of our partners often for both their and our own benifit, 'to share is to multiply'. The senior staff members of Sanquin Research Departments are opinion leaders in the field that are at all times willing to discuss your suggestions for co-development.
For legal and contract issues please contact the Manager Business Development Research.

To get an idea of the range of research performed at different departments please consult the following page(s):
  • Plasma Proteins
  • Blood Cell Research
  • Experimental Immunohematology
  • Immunopathology 
  • Blood Bank research

    Our co-development contracts define amongst others R&D objective, legal aspects concerning IP-rights and licenses, mutual contributions/responsibilities related to recources (personnel, facilities, financing), management, royalties, deliverables/milestones and related timelines. To ensure confidentiality Sanquin works with (mutual) Non Disclosure Agreements in order to facilitate exchange of information.
    Sanquin Research is familiar with both Dutch and EU regulations/funds to stimulate economic activities in the biotech, blood transfusion and plasma fractionation -related and/or pharmaceutical fields. We have successfully obtained funds through cooperative ventures with start-ups, established companies and research institutes.

    Top


    • « back